BIND Score for Severe Neonatal Jaundice in NICU

This study focuses on evaluating the effectiveness of the BIND score in predicting and diagnosing severe jaundice in newborns who are in the neonatal intensive care unit (NICU). Severe jaundice can lead to serious conditions such as neonatal encephalopathy, which affects the baby's brain. The goal is to find out if using the BIND score can help detect these issues early, allowing for timely treatment and potentially preventing further complications. This study is crucial because early intervention could improve outcomes for newborns with high bilirubin levels, which is the substance that causes jaundice. Participants in this study will have their neurological condition assessed using the BIND score, a tool that helps evaluate the severity of jaundice-related brain issues. Following this assessment, phototherapy, a common treatment for reducing bilirubin levels, will be administered. The study will measure how well the BIND score predicts the need for such treatment and its overall effectiveness in managing jaundice. By determining the BIND score's predictive and diagnostic value, the study aims to enhance the care provided to newborns with severe jaundice, ultimately reducing the risk of brain damage.